Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Pankaj Mandal
Title
Principal Investigator
Bio
Pankaj Mandal is a Principal Investigator at CBER, FDA. He received his PhD in Veterinary Medicine from Ludwig Maximilian University, Munich in 2009. He joined Boston Children’s Hospital/Harvard Medical School for his postdoctoral research on cellular reprogramming, developed Hematopoietic Stem Cell (HSC)-specific reporter strains of mice, and evaluated the efficacy of CRISPR/Cas9 genome editing in human HSCs. He started his research group at CBER in 2019. His research work is focused on understanding HSC biology and advanced manufacturing of CRISPR-edited HSC-based therapeutics.
